Your browser doesn't support javascript.
loading
Balancing the Expression and Production of a Heterodimeric Protein: Recombinant Agkisacutacin as a Novel Antithrombotic Drug Candidate.
Guo, Yugang; Wu, Jing; Jia, Hao; Chen, Wei; Shao, Changsheng; Zhao, Lei; Ma, Jiajia; Li, Rui; Zhong, Yongjun; Fang, Fang; Wang, Dong; Sun, Jie; Qian, Fang; Dai, Xiangrong; Zhang, Guohui; Tian, Zhigang; Xiaoyi Li, Benjamin; Xiao, Weihua.
Affiliation
  • Guo Y; 1] The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China [2] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biot
  • Wu J; 1] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biotechnology Drugs, Anhui Province, University of Science and Technology of China, Hefei, China [2] Anhui Engineering Research Center of Recombinant Protein Pharmaceutical Biotechnology, Inst
  • Jia H; The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Chen W; 1] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biotechnology Drugs, Anhui Province, University of Science and Technology of China, Hefei, China [2] Anhui Engineering Research Center of Recombinant Protein Pharmaceutical Biotechnology, Inst
  • Shao C; 1] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biotechnology Drugs, Anhui Province, University of Science and Technology of China, Hefei, China [2] Anhui Engineering Research Center of Recombinant Protein Pharmaceutical Biotechnology, Inst
  • Zhao L; 1] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biotechnology Drugs, Anhui Province, University of Science and Technology of China, Hefei, China [2] Anhui Engineering Research Center of Recombinant Protein Pharmaceutical Biotechnology, Inst
  • Ma J; 1] The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China [2] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biot
  • Li R; The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Zhong Y; The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Fang F; The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Wang D; The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Sun J; 1] The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China [2] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biot
  • Qian F; Zhaoke Pharmaceutical (Hefei) Co. Ltd., Hefei, Anhui, China.
  • Dai X; Zhaoke Pharmaceutical (Hefei) Co. Ltd., Hefei, Anhui, China.
  • Zhang G; Zhaoke Pharmaceutical (Hefei) Co. Ltd., Hefei, Anhui, China.
  • Tian Z; 1] The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China [2] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biot
  • Xiaoyi Li B; Lee's Pharmaceutical Holdings Limited, Shatin, Hong Kong, China.
  • Xiao W; 1] The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, China [2] Hefei National Laboratory for Physical Sciences at Microscale, Engineering Technology Research Center of Biot
Sci Rep ; 5: 11730, 2015 Jul 06.
Article in En | MEDLINE | ID: mdl-26144864
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crotalid Venoms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2015 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crotalid Venoms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2015 Document type: Article Country of publication: United kingdom